PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 20 | 238-247
Article title

Physiotherapeutic Management of People Living with HIV/AIDS

Content
Title variants
Languages of publication
EN
Abstracts
EN
The Human immunodeficiency virus (HIV) is a lentivirus that causes HIV infection, and over time, Acquired Immunodeficiency Syndrome (AIDS). HIV infection (simply called HIV at its early stage and AIDS at its later stage) is a very prevalent global disease condition affecting about 36.7 million people, both young and old. Sadly, HIV/AIDS affects almost all the systems in the body (particularly the neurological and musculoskeletal systems), which may result into physical disability. Physiotherapists are known to play important roles in the management of physical disability. In this paper, the authors provide information on the clinical and epidemiological features of HIV/AIDS, as well as the treatment modalities for the neurological and musculoskeletal problems experienced by people living with HIV/AIDS.
Keywords
Discipline
Year
Volume
20
Pages
238-247
Physical description
Contributors
References
  • [1] Anaan N, Braveman B, Kielhofner G and Forsyth K (2006). Impairments and perceived competence persons living with HIV/AIDS. Work 27(3):255-266.
  • [2] Bell J (1998). The neuropathy of adult HIV disease. Revque Neurolique 154: 816- 829.
  • [3] Capbloblanchi MR, Barresi C, Gessani S, Fantuzzi L, Amegelio F, Belardelli F et al (1997) Human immunodeficiency type 1 gp120 stimulates cytomegalovirusreplication in monocytes: possible role of endogenous interleukin-8. Journal of Virology 71(2): 1591-1597
  • [4] Cunningham A, Donaghy H, Harman A, Kim M, Turville S (2010). Manipulation of dendritic cell function by viruses. Current Opinion in Microbiology 13 (4): 524–529.
  • [5] Doitsh G, Galloway NL, Geng X, Yang Z; Monroe KM, Zepeda O et al (2014). Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505 (7484): 509–514.
  • [6] Douek DC, Roederer M and Koup RA. Emerging Concepts in the Immunopathogenesis of AIDS. Annual Review of Medicine 60 (2009) 471–84.
  • [7] Faria NR, Rambaut A, Suchard MA, Baele G, Bedford T , Ward MJ et al (2014). The early spread and epidemic ignition of HIV-1 in human populations. Science 346 (6205): 56–61
  • [8] Fillipas S, Oldmeadow L, Bailey M , and Cherry C. (2006). A six month, supervised, aerobic and resistance exercise programme improves self-efficacy in people with human immunodeficiency virus: A randomized controlled trial. Australian Journal of Physiotherapy 52, 185-190.
  • [9] Freeman R, Roberts M and Freidman (1990). Autonomic function and human immunodeficiency virus. Neurology 50: 575-580.
  • [10] Fernadez F (1990). Neuropsychiatric syndromes and their treatment in HIV infection, In a psychiatric’s guide to HIV and AIDS disease. American Pscyhiatric Association.
  • [11] Gale, J. (2003). Physiotherapy intervention in two people with HIV or AIDS-related peripheral neuropathy. Physiotherapy Research International 8 (4), 200-207.
  • [12] Galantine M, Jermyn R and Tursi F (1998). Physical therapy management for the patient with HIV: lower extremities. Clinics in Podiatric Medicine and Surgery 15: 329-346.
  • [13] Garg H, Mohl J and Joshi A (2012). HIV-1 induced bystander apoptosis. Viruses 4 (11): 3020–43.
  • [14] Gilbert B, McKeague W, Eisen G, Mullins C, Guéye-NDiaye A, Mboup S and Kanki PJ (2003). Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Statistics in Medicine 22(4): 573–593.
  • [15] Hand G, Phillips K, Dudgeon W, Lyerly G, Durstine J and Burgess S.(2008). Moderate intensity exercise training reverses functional aerobic impairment in HIV-infected individuals. AIDS Care 20 (9): 1066-1074.
  • [16] Harris-Love, M. O, and Shrader J A. (2004). Physiotherapy management of patients with HIV-associated Kaposi’s sarcoma. Physiotherapy Research International (4), 174-181.
  • [17] HIV/AIDS. Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/hiv aids/basics/symptoms/con-20013732. Accessed October 22 2017.
  • [18] HIV/AIDS. Center for Disease Control and Prevention. http://www.cdc.gov/hiv/default.html. Accessed October 22, 2017.
  • [19] Kumar, Vinay (2012). Robbins Basic Pathology (9th ed.). p. 147. ISBN 9781455737871.
  • [20] Levy JA (1993). HIV pathogenesis and long-term survival. AIDS Science 7 (11): 1401–1410.
  • [21] Malita F M, Karelis A D, Toma E, and Rabassa-Lhoret, R. (2005). Effect of different types of exercise on body composition and fat distribution in HIV-infected patients. Canadian Journal of Applied Physiology 30 (2): 233-245.
  • [22] McReynolds C and Garske G (2001). Current issues in HIV disease and AIDS; Implications for health and rehabilitation professionals, Work. 17: 117-124.
  • [23] Miller, T (2007). Hospital-Based exercise Program to improve Body composition, strength and abdominal adiposity in 2 HIV-infected children. The AIDS Reader 17 (9): 450.
  • [24] Mutimura E, Stewart A, Crowther NJ, Yarasheski KE and Cade WT. (2008) The effects of exercise training on quality of life in HAART-related HIV-positive Rwandan subjects with body fat distribution. Quality of Life Research (17) 377-385.
  • [25] New CDC Recommendations for HIV Testing in Laboratories. (https://www.cdc.gov/nchhstp/newsroom/docs/2014/HIV-testing-Labs-Flowchart.pdf) (PDF).cdc.gov. Centers for Disease Control and Prevention. Accessed October, 22, 2017.
  • [26] Nunley J (2000). Cutaneous manifestations of HIV and HCV. Dermatology Nursing (12): 163-169.
  • [27] Palella F, Moorman A and Delancy K (1998). Dramatically declining morbidity and mortality in an ambulatory HIV-infected population. In Abstracts of the 5th Conference on Retroviruses and Oppurtunistic Infections, Chicago, February 1-5, 199
  • [28] Physical Therapist’s Guide to HIV Disease and AIDS. American Physical Therapy Association. http://www.moveforwardpt.com/symptomsconditionsdetail.aspx?cid=931ce05b-4b22-49529b18-34af9e201f8d#.UzGRfNnOTp , Accessed October 22, 2017.
  • [29] Plebani A, Pinzani R, Startari R, Brusa D. and Padoan R. (1997), Usefulness of chest physiotherapy with Positive Expiratory Pressure (PEP)-mask in HIV-infected children with recurrent pulmonary infections. Acta Pædiatrica 86: 1195–1197
  • [30] O’Brien K, Nixon S, Glazier, R and Tinan (2004). Progressive resistive exercise interventions foe the adults living with HIV/AIDS. Cochrane Database of systematic Reviews, 18 (4).
  • [31] O'Brien K, Tynan A, Nixon S and Glazier R. (2008). Effects of progressive resistive exercise in adults living with HIV/AIDS: systematic review and meta-analysis of randomized trials. AIDS Care 20: 631-653. Accessed October 22, 2017.
  • [32] Reeves J and Doms R (2002). Human Immunodeficiency Virus Type 2. Journal of General Virology 83 (6):1253–65.
  • [33] Sharp PM and Hahn BH (2011). Origins of HIV and the AIDS Pandemic. Cold Spring Harbor perspectives in medicine 1 (1), doi: 10.1101/cshperspect.a006841
  • [34] Simpson DM, Tagilati M and Grinell J (1994). Electrophysiological findings in HIV infection: association with distal symmetrical polyneuropathy and CD4+. Muscle Nerve 17: 1113.
  • [35] Steinbach L, Tehranzedah J and Fleckenstein J (1993). Musculoskeletal manifestations of human immunodeficiency virus (HIV) infection. Radiology 186: 833-838
  • [36] Taylor NF, Dodds KJ, Shields N and Bruder A (2007). Therapeutic exercise in physiotherapy practice is beneficial: a summary of systematic reviews 2002-2005. Australian Journal of Physiotherapy 53: 7-16.
  • [37] Harsh Mohan, (2010) Textbook of Pathology by 6th Ed. Jaypee Brothers, New Delhi Brothers.
  • [38] Ungvarski P and Trzcianowska H (2000). Neurocognitive disorders seen in HIV disease. Issues Ment Health Nursing 21: 51-77.
  • [39] U.S. Department of Health and Human Services. HIV/AIDS Basics. AIDS.gov. http://aids.gov/hiv-aids-basics. Accessed November 1, 2017
  • [40] Useh U, Akinpelu AO and Makinde GB (2003). HIV/AIDS pandemic comparative knowledge and roles of physiotherapists in two African countries. Physiotherapy, 89 (12): 20-727.
  • [41] Vidya VK, Karthigeyan KP, Tripathi SP and Hanna LE (2017). Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 infections. Frontiers in Immunology (8): 580
  • [42] Voors M (2000). Ethics and HIV/AIDS. Physiotherapy 86(12): 640-644
  • [43] Weiss RA (1993). How does HIV cause AIDS? Science 260 (5112).
  • [44] Witte M, Witte C and Way M (1990). AIDS. Kaposi sarcoma and the lymphatic: update and reflections. Lymphology 23: 73-80.
  • [45] Worthington C, Myers T, O’Brien K, Nixon S, Cockeril R and Bereket, T. (2005). Rehabilitation professionals and human immunodeficiency virus care: Results of a Canadian survey. Archives of Physical Medicine and Rehabilitation (89). 105-113.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-6409504e-9c82-4634-aa92-31b60f4f0b44
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.